Drugs to limit Zika virus infection and implication for maternal-fetal health.

Kumar A, Kumar D, Jose J, Giri R, Mysorekar IU

DOI: 10.3389/fviro.2022.928599
Published: 2022
Container: Frontiers in virology (Lausanne, Switzerland)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fviro.2022.928599,
  title = {Drugs to limit Zika virus infection and implication for maternal-fetal health.},
  author = {Kumar A and Kumar D and Jose J and Giri R and Mysorekar IU},
  year = {2022},
  journal = {Frontiers in virology (Lausanne, Switzerland)},
  doi = {10.3389/fviro.2022.928599},
  url = {https://doi.org/10.3389/fviro.2022.928599}
}

RIS

TY  - JOUR
TI  - Drugs to limit Zika virus infection and implication for maternal-fetal health.
AU  - Kumar A
AU  - Kumar D
AU  - Jose J
AU  - Giri R
AU  - Mysorekar IU
PY  - 2022
JO  - Frontiers in virology (Lausanne, Switzerland)
DO  - 10.3389/fviro.2022.928599
UR  - https://doi.org/10.3389/fviro.2022.928599
ER  -

APA

A, K., D, K., J, J., R, G., & IU, M. (2022). Drugs to limit Zika virus infection and implication for maternal-fetal health.. Frontiers in virology (Lausanne, Switzerland). https://doi.org/10.3389/fviro.2022.928599

Source records

pubmed · retrieved 2026-11-10T14:06:17.927Z